SC
STAA icon

SummitTX Capital’s STAAR Surgical STAA Stock Holding History

SummitTX Capital’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,900
Closed -$783K – 955
2025
Q4 		$783K Buy
+33,900
New +$874K 0.02% 454

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SummitTX Capital's STAA Position: Q1 2026 in Review

SummitTX Capital sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 46,373 shares — an estimated $1.07M sold.

SummitTX Capital first reported a position in STAA in Q3 2025 and held it in 2 quarters. The position peaked at $1.75M in Q3 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • SummitTX Capital reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • SummitTX Capital sold 46,373 STAAR Surgical shares in Q1 2026, an estimated $1.07M.
  • SummitTX Capital first reported a position in STAAR Surgical in Q3 2025 and held it in 2 quarters.
  • SummitTX Capital's STAAR Surgical position peaked at $1.75M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.